MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes

por Pourhassan, H, DeFor, T, Trottier, B, Dolan, M, Brunstein, C, Bejanyan, N, Ustun, C, Warlick, E D
Publicado 2016

P1049: A PHASE 2 STUDY OF BEZUCLASTINIB (CGT9486), A NOVEL, HIGHLY SELECTIVE, POTENT KIT D816V INHIBITOR, IN ADULTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (APEX): METHODS, BASELINE DA...

por DeAngelo, D. J., Pullarkat, V., Piris-Villaespesa, M., George, T. I., Patel, J. L., Ustun, C., Bose, P., Heaney, M. L., Pilla, A., Massaro, M., Exter, B., Jolin, H. A., Mikhak, Z., Tashi, T.
Publicado 2022